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Abstract summary 
Polycations are frequently reported to tailor drug delivery systems, there is still a need to better correlate their 
macromolecular features with their biocompatibility, in particular with blood. In this view, we have analysed the 
RBC aggregation and hemolysis response caused by poly (dimethylamino-ethylmethacrylate) or 
poly(ethyleneimine) under a free form, i.e. without their preliminary association with polyanionic drug. Our 
results highlight that the molecular weight of PDMAEMA significantly affects the RBC aggregation without 
inducing any hemolysis. 
 
Introduction 
Positively charged polymers, commonly named polycations, are widely used as carriers in drug delivery 
research. However, if cationic nanocarriers are intravenously injected, they may interact with several blood 
elements [1]. Their hemocompatibility have been reported by several authors, evaluating their ability to induce 
RBC aggregation and hemolysis.These tests have been particularly reported for two of the most common 
polycations explored for gene delivery: Poly(ethylenimine) (PEI) and poly(dimethylamino-ethylmethacrylate) 
(PDMAEMA). However, until now most of these tests have been usually applied considering polyelectrolyte 
complexes and not the free form of these polycations [2-3]. Considering that these complexes could potentially 
dissociate either in the blood itself or later on, it was also important to better analyze their biological behavior 
when diluted in the blood under a free form. Interaction between negatively charged red blood cells (RBC) and 
polycations is especially important because it may provoke RBC aggregation or hemolytic responses [2]. 
Although the decrease in Zeta potential resulting from the electrostatic adsorption of the polycations to the 
erythrocyte surface can explain such responses, other factors depending of the molecular weight and free 
polymer concentration could also affect this reactivity [4]. In this respect, RBC aggregation and hemolytic 
response were evaluated in human whole blood considering three PDMAEMA with Mw ranging from 10,000 to 
40,000, one block copolymer of PDMAEMA-b-Poly(ethylene glycol) (PEG) copolymer (Mw 30,700) and a PEI 
(Mw : 10,000). 
Experimental methods 
Three linear PDMAEMA homopolymers of distinct Mw (Table 1) and one linear PDMAEMA-b-PEG 
copolymer were synthesized by living radical polymerization [2]. These polymers were extensively purified after 
preparation in view to eliminate any solvent, catalyst and monomer residues. Branched PEI was purchased from 
Polysciences Europe. Polymer solutions in isotonic PBS (pH 7.4) were diluted in whole blood (1/10 volume) in 
cylindrical Eppendorf tubes and incubated at 37 °C during 15 to 240 min under roller agitation. After incubation, 
RBC aggregation was evaluated by inverted optical microscope (25x) analyzing at least 3 fields to have a 
statistic overview of the samples. Percentage of hemolysis was measured adopting ASTM method (F 756-00). 
Saponine (0.8 mg/mL) was adopted as positive control and PBS as negative control. 
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Table 1 PDMAEMA based polymers and PEI from commercial origin. 
Polymer Code Mn, Mw Polymer concentration (µg/mL) 
PDMAEMA P1 10,000 10, 100, 200, 500, 1000 
PDMAEMA P2 26,400  
PDMAEMA P3 40,000  
PDMAEMA-b-PEG (FDMAEMA =  95%) P4 30,700  
PEI P5 10,000  
 
Table 2 Score of red blood cell aggregation: (—) single cells; (+R) single cells, doublets, triplets and rouleaux; 
(++) slight aggregation with presence of single cells; ( +++) strong aggregation with presence of single cells; 
(++++) strong aggregation without presence of single cells; (+++++) strong aggregation in all the visual 
fields. 
 15 minutes incubation 60 minutes incubation 120 minutes incubation 240 minutes incubation 
 Concentration (µg/ml) Concentration (µg/ml) Concentration (µg/ml) Concentration (µg/ml) 
 10 100 200 500 1000 10 100 200 500 1000 10 100 200 500 1000 10 100 200 500 1000 
P1 - - - - - - - - - - - - - - - - - - - - 
P2 - - - + + + + + - - - + + + + + + - - - + + + + + + - - - + + + + + + + + 
P3 - - + R + + + + + + + - - + R + + + + + + + - - + R + + + + + + + - - + + + + + + + + + + + + 
P4 - - - - - - - - - - - - - - - - - - - - 
P5 - - - - - - - - - - - - - - - - - - - + R 
 
Results and discussion 
Results of aggregation are shown as score in Table 2. This shows that the Mw of the PDMAEMA largely affects 
the aggregation. Indeed the lowest Mw of this polycation (P1) does not induce any cell aggregation, whilst RBC 
aggregates are readily observed with P2 at 500 µg/mL and P3 at 200 µg/mL These observations support the 
assumption that the aggregation of the blood cells requires at least the combination of two physical factors. The 
first one relies upon a decrease of their Zeta potential by neutralisation of the negative charges present at the 
plasma membrane surface. The second one depends on a physical cross-linking between cells (bridging of cells 
with the poly electrolytes) which will be obviously facilitated by the use of longer polycation chains. 
 
Fig. 1. Hemoglobin release is expressed in percentage. Responses lower than 2% are considered non-hemolytic; 
between 2 and 4% slightly hemolytic; and higher than 4% is considered hemolytic. 
 
 
The difference of hemoreactivity of P4 is interesting to emphasis. Indeed in spite of its higher molecular weight, 
no aggregation has been noticed whatever the duration and polycation concentration assessed. This profound 
difference in hemoreactivity can be explained by the steric protection afforded by the PEG moieties present in 
this copolymer. 
Indeed it can be anticipated that the shielding of the PEG chains could significantly reduce the cross-linking 
action of the polycation segments. A slight RBC aggregation was observed with PEI, but only at the highest 
concentration (1 mg/mL) and after 4 h of incubation. Compared to PDMAEMA this difference could be at least 
explained by the difference in macromolecule flexibility between these two polymers. In this respect the 
hemolytic ability is most interesting to compare between PEI and the PDMAEMA based polymers. PEI 
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provokes indeed higher hemoglobin release by analogy to the other polycations evaluated. Indeed whatever their 
molecular weight and composition no hemolytic response has been noticed with the PDMAEMA's under our 
experimental conditions (image 2). In opposite, PEI caused slight hemolytic response depending on incubation 
time and concentration. In distinct mammalian cells, the toxicity of PEI is related to bind of this polycation to 
plasma membrane proteoglycans, causing membrane destabilization with redistribution of phosphatidylserine 
[5]. Cytotoxicity has been observed in mammalian cells incubated with PDMAEMA. It has been related to 
internalization of polymer [6]. In RBC, toxic mechanism could be similar to mechanism observed for 
mammalian cells. Based in our results, the cytotoxicity activity for RBC is stronger for the PEI than 
PDMAEMA. 
Conclusion 
The present experiment showed that the RBC aggregation can proceed very quickly and intensively when 
incubated with homoPDMAEMA of Mw above than 10,000. This aggregation ability can however be totally 
prevented if PEG moieties are grafted in the polycation sequence. The comparison in the hemoreactivity of the 
PEI with homoPDMAEMA was interesting highlighting clearly that: RBC aggregation and hemolysis are 
independent responses, and the difference in membrane interaction between two families of polycations. 
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